Skip to main content
Journal cover image

Vascular α1-Adrenergic Receptor Responsiveness in Masked Hypertension.

Publication ,  Journal Article
Yano, Y; Viera, AJ; Hinderliter, AL; Watkins, LL; Blumenthal, JA; Johnson, KS; Hill, LK; Sherwood, A
Published in: Am J Hypertens
August 4, 2020

BACKGROUND: Masked hypertension (nonhypertensive in the clinic setting but hypertensive outside the clinic during wakefulness) is characterized by increased blood pressure in response to physical and emotional stressors that activate the sympathetic nervous system (SNS). However, no studies have assessed vascular reactivity to a pharmacological SNS challenge in individuals with masked hypertension. METHODS: We analyzed data from 161 adults aged 25 to 45 years (mean ± standard deviation age 33 ± 6 years; 48% were African American and 43% were female). Participants completed ambulatory blood pressure monitoring, and a standardized α 1-adrenergic agonist phenylephrine test that determines the dose of phenylephrine required to increase a participant's mean arterial pressure by 25 mm Hg (PD25). RESULTS: Twenty-one participants were considered to have masked hypertension (clinic systolic blood pressure (SBP) <140 and diastolic blood pressure (DBP) <90 mm Hg but awake SBP ≥135 or DBP ≥85 mm Hg), 28 had sustained hypertension (clinic SBP ≥140 or DBP ≥90 mm Hg and awake SBP ≥135 or DBP ≥85 mm Hg), and 106 had sustained normotension (clinic SBP <140 and DBP <90 mm Hg and awake SBP <135 and DBP <85 mm Hg). After multivariable adjustment, the mean (±SE) PD25 was less in participants with masked hypertension compared with their counterparts with sustained normotension (222.1 ± 33.2 vs. 328.7 ± 15.0; P = 0.012), but similar to that observed in subjects with sustained hypertension (254.8 ± 31.0; P =0.12). CONCLUSIONS: Among young and middle-aged adults, masked hypertension is associated with increased vascular reactivity to a SNS challenge, which may contribute to elevated awake BPs as well as to increased cardiovascular disease risk.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Hypertens

DOI

EISSN

1941-7225

Publication Date

August 4, 2020

Volume

33

Issue

8

Start / End Page

713 / 717

Location

United States

Related Subject Headings

  • White People
  • Sympathetic Nervous System
  • Receptors, Adrenergic, alpha-1
  • Phenylephrine
  • Multivariate Analysis
  • Masked Hypertension
  • Male
  • Humans
  • Female
  • Dose-Response Relationship, Drug
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yano, Y., Viera, A. J., Hinderliter, A. L., Watkins, L. L., Blumenthal, J. A., Johnson, K. S., … Sherwood, A. (2020). Vascular α1-Adrenergic Receptor Responsiveness in Masked Hypertension. Am J Hypertens, 33(8), 713–717. https://doi.org/10.1093/ajh/hpaa032
Yano, Yuichiro, Anthony J. Viera, Alan L. Hinderliter, Lana L. Watkins, James A. Blumenthal, Kristy S. Johnson, LaBarron K. Hill, and Andrew Sherwood. “Vascular α1-Adrenergic Receptor Responsiveness in Masked Hypertension.Am J Hypertens 33, no. 8 (August 4, 2020): 713–17. https://doi.org/10.1093/ajh/hpaa032.
Yano Y, Viera AJ, Hinderliter AL, Watkins LL, Blumenthal JA, Johnson KS, et al. Vascular α1-Adrenergic Receptor Responsiveness in Masked Hypertension. Am J Hypertens. 2020 Aug 4;33(8):713–7.
Yano, Yuichiro, et al. “Vascular α1-Adrenergic Receptor Responsiveness in Masked Hypertension.Am J Hypertens, vol. 33, no. 8, Aug. 2020, pp. 713–17. Pubmed, doi:10.1093/ajh/hpaa032.
Yano Y, Viera AJ, Hinderliter AL, Watkins LL, Blumenthal JA, Johnson KS, Hill LK, Sherwood A. Vascular α1-Adrenergic Receptor Responsiveness in Masked Hypertension. Am J Hypertens. 2020 Aug 4;33(8):713–717.
Journal cover image

Published In

Am J Hypertens

DOI

EISSN

1941-7225

Publication Date

August 4, 2020

Volume

33

Issue

8

Start / End Page

713 / 717

Location

United States

Related Subject Headings

  • White People
  • Sympathetic Nervous System
  • Receptors, Adrenergic, alpha-1
  • Phenylephrine
  • Multivariate Analysis
  • Masked Hypertension
  • Male
  • Humans
  • Female
  • Dose-Response Relationship, Drug